# Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Source: https://welltoldgrants.com/grants/rfa-ts-25-036-identify-and-evaluate-potential-risk-factors-for-amyotrophic/  
Official notice: https://www.grants.gov/search-results-detail/353975

> Centers for Disease Control and Prevention - ERA offered grants of up to $500,000 to any type of organization. It expected to make about 8 awards worth $7.5 million in total. Applications closed on November 4, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-TS-25-036 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | November 4, 2024 |
| Award ceiling | $500,000 |
| Award floor | not stated |
| Expected awards | 8 |
| Total funding | $7.5 million |
| Cost sharing | not required |
| Assistance Listings | 93.061 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

See Section III. Eligibility Information.

## What the grant funds

The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.

## Questions people ask

### Is RFA-TS-25-036 still open?

No. It closed on November 4, 2024. A newer notice is forecast: RFA-TS-27-018, expected deadline February 1, 2027.

### Who can apply for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?

Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?

Closed November 4, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $500,000 each. About $7.5 million in total across about 8 awards.

### Who has won Innovations in Applied Public Health Research grants before?

The largest recipients over five fiscal years were President and Fellows of Harvard College, Firebird Biomolecular Sciences LLC, Regents of the University of Michigan. The program made 7 awards worth $3.9 million in that time.